The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Celiac Drugs Market Research Report 2025
Synopsis
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
The global Celiac Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Celiac Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Drugs.
Report Scope
The Celiac Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Celiac Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celiac Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
Segment by Type
First Line Of Treatment
Second Line Of Treatment
Segment by Application
Men
Women
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Celiac Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
The global Celiac Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Celiac Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Drugs.
Report Scope
The Celiac Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Celiac Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celiac Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
Segment by Type
First Line Of Treatment
Second Line Of Treatment
Segment by Application
Men
Women
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Celiac Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Celiac Drugs Market Overview
1.1 Product Overview and Scope of Celiac Drugs
1.2 Celiac Drugs Segment by Type
1.2.1 Global Celiac Drugs Market Value Comparison by Type (2024-2030)
1.2.2 First Line Of Treatment
1.2.3 Second Line Of Treatment
1.3 Celiac Drugs Segment by Application
1.3.1 Global Celiac Drugs Market Value by Application: (2024-2030)
1.3.2 Men
1.3.3 Women
1.3.4 Children
1.4 Global Celiac Drugs Market Size Estimates and Forecasts
1.4.1 Global Celiac Drugs Revenue 2019-2030
1.4.2 Global Celiac Drugs Sales 2019-2030
1.4.3 Global Celiac Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Celiac Drugs Market Competition by Manufacturers
2.1 Global Celiac Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Celiac Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Celiac Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Celiac Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Celiac Drugs, Product Type & Application
2.7 Celiac Drugs Market Competitive Situation and Trends
2.7.1 Celiac Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Celiac Drugs Players Market Share by Revenue
2.7.3 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Celiac Drugs Retrospective Market Scenario by Region
3.1 Global Celiac Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Celiac Drugs Global Celiac Drugs Sales by Region: 2019-2030
3.2.1 Global Celiac Drugs Sales by Region: 2019-2024
3.2.2 Global Celiac Drugs Sales by Region: 2025-2030
3.3 Global Celiac Drugs Global Celiac Drugs Revenue by Region: 2019-2030
3.3.1 Global Celiac Drugs Revenue by Region: 2019-2024
3.3.2 Global Celiac Drugs Revenue by Region: 2025-2030
3.4 North America Celiac Drugs Market Facts & Figures by Country
3.4.1 North America Celiac Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Celiac Drugs Sales by Country (2019-2030)
3.4.3 North America Celiac Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Celiac Drugs Market Facts & Figures by Country
3.5.1 Europe Celiac Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Celiac Drugs Sales by Country (2019-2030)
3.5.3 Europe Celiac Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Celiac Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Celiac Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Celiac Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Celiac Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Celiac Drugs Market Facts & Figures by Country
3.7.1 Latin America Celiac Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Celiac Drugs Sales by Country (2019-2030)
3.7.3 Latin America Celiac Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Celiac Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Celiac Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Celiac Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Celiac Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Celiac Drugs Sales by Type (2019-2030)
4.1.1 Global Celiac Drugs Sales by Type (2019-2024)
4.1.2 Global Celiac Drugs Sales by Type (2025-2030)
4.1.3 Global Celiac Drugs Sales Market Share by Type (2019-2030)
4.2 Global Celiac Drugs Revenue by Type (2019-2030)
4.2.1 Global Celiac Drugs Revenue by Type (2019-2024)
4.2.2 Global Celiac Drugs Revenue by Type (2025-2030)
4.2.3 Global Celiac Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Celiac Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Celiac Drugs Sales by Application (2019-2030)
5.1.1 Global Celiac Drugs Sales by Application (2019-2024)
5.1.2 Global Celiac Drugs Sales by Application (2025-2030)
5.1.3 Global Celiac Drugs Sales Market Share by Application (2019-2030)
5.2 Global Celiac Drugs Revenue by Application (2019-2030)
5.2.1 Global Celiac Drugs Revenue by Application (2019-2024)
5.2.2 Global Celiac Drugs Revenue by Application (2025-2030)
5.2.3 Global Celiac Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Celiac Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ADMA Biologics
6.1.1 ADMA Biologics Corporation Information
6.1.2 ADMA Biologics Description and Business Overview
6.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ADMA Biologics Celiac Drugs Product Portfolio
6.1.5 ADMA Biologics Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amgen Celiac Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Anthera Pharmaceuticals
6.3.1 Anthera Pharmaceuticals Corporation Information
6.3.2 Anthera Pharmaceuticals Description and Business Overview
6.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
6.3.5 Anthera Pharmaceuticals Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Celiac Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Corporation Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biogen Celiac Drugs Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 BioLineRx
6.6.1 BioLineRx Corporation Information
6.6.2 BioLineRx Description and Business Overview
6.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BioLineRx Celiac Drugs Product Portfolio
6.6.5 BioLineRx Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Celiac Drugs Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Celgene
6.9.1 Celgene Corporation Information
6.9.2 Celgene Description and Business Overview
6.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Celgene Celiac Drugs Product Portfolio
6.9.5 Celgene Recent Developments/Updates
6.10 Celimmune
6.10.1 Celimmune Corporation Information
6.10.2 Celimmune Description and Business Overview
6.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Celimmune Celiac Drugs Product Portfolio
6.10.5 Celimmune Recent Developments/Updates
6.11 F Hoffmann-La Roche
6.11.1 F Hoffmann-La Roche Corporation Information
6.11.2 F Hoffmann-La Roche Celiac Drugs Description and Business Overview
6.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
6.11.5 F Hoffmann-La Roche Recent Developments/Updates
6.12 ImmunogenX
6.12.1 ImmunogenX Corporation Information
6.12.2 ImmunogenX Celiac Drugs Description and Business Overview
6.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ImmunogenX Celiac Drugs Product Portfolio
6.12.5 ImmunogenX Recent Developments/Updates
6.13 Immunomedics
6.13.1 Immunomedics Corporation Information
6.13.2 Immunomedics Celiac Drugs Description and Business Overview
6.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Immunomedics Celiac Drugs Product Portfolio
6.13.5 Immunomedics Recent Developments/Updates
6.14 ImmusanT
6.14.1 ImmusanT Corporation Information
6.14.2 ImmusanT Celiac Drugs Description and Business Overview
6.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ImmusanT Celiac Drugs Product Portfolio
6.14.5 ImmusanT Recent Developments/Updates
6.15 Innovate Biopharmaceuticals
6.15.1 Innovate Biopharmaceuticals Corporation Information
6.15.2 Innovate Biopharmaceuticals Celiac Drugs Description and Business Overview
6.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
6.15.5 Innovate Biopharmaceuticals Recent Developments/Updates
6.16 Johnson & Johnson
6.16.1 Johnson & Johnson Corporation Information
6.16.2 Johnson & Johnson Celiac Drugs Description and Business Overview
6.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Johnson & Johnson Celiac Drugs Product Portfolio
6.16.5 Johnson & Johnson Recent Developments/Updates
6.17 Kedrion Biopharma
6.17.1 Kedrion Biopharma Corporation Information
6.17.2 Kedrion Biopharma Celiac Drugs Description and Business Overview
6.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kedrion Biopharma Celiac Drugs Product Portfolio
6.17.5 Kedrion Biopharma Recent Developments/Updates
6.18 LFB Group
6.18.1 LFB Group Corporation Information
6.18.2 LFB Group Celiac Drugs Description and Business Overview
6.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 LFB Group Celiac Drugs Product Portfolio
6.18.5 LFB Group Recent Developments/Updates
6.19 Merck
6.19.1 Merck Corporation Information
6.19.2 Merck Celiac Drugs Description and Business Overview
6.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Merck Celiac Drugs Product Portfolio
6.19.5 Merck Recent Developments/Updates
6.20 Novartis
6.20.1 Novartis Corporation Information
6.20.2 Novartis Celiac Drugs Description and Business Overview
6.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Novartis Celiac Drugs Product Portfolio
6.20.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Celiac Drugs Industry Chain Analysis
7.2 Celiac Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Celiac Drugs Production Mode & Process
7.4 Celiac Drugs Sales and Marketing
7.4.1 Celiac Drugs Sales Channels
7.4.2 Celiac Drugs Distributors
7.5 Celiac Drugs Customers
8 Celiac Drugs Market Dynamics
8.1 Celiac Drugs Industry Trends
8.2 Celiac Drugs Market Drivers
8.3 Celiac Drugs Market Challenges
8.4 Celiac Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Celiac Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Celiac Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Celiac Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Celiac Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Celiac Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Celiac Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Celiac Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Celiac Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Celiac Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Celiac Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Celiac Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Celiac Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Celiac Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Celiac Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Celiac Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Celiac Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Celiac Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Celiac Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Celiac Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Celiac Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Celiac Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Celiac Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Celiac Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Celiac Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Celiac Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Celiac Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Celiac Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Celiac Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Celiac Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Celiac Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Celiac Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Celiac Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Celiac Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Celiac Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Celiac Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Celiac Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Celiac Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Celiac Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Celiac Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Celiac Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Celiac Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Celiac Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Celiac Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Celiac Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Celiac Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Celiac Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Celiac Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Celiac Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Celiac Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Celiac Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Celiac Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Celiac Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Celiac Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Celiac Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Celiac Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Celiac Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Celiac Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Celiac Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Celiac Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Celiac Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Celiac Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Celiac Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Celiac Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Celiac Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Celiac Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Celiac Drugs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Celiac Drugs Price (USD/Unit) by Application (2025-2030)
Table 70. ADMA Biologics Corporation Information
Table 71. ADMA Biologics Description and Business Overview
Table 72. ADMA Biologics Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. ADMA Biologics Celiac Drugs Product
Table 74. ADMA Biologics Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Amgen Celiac Drugs Product
Table 79. Amgen Recent Developments/Updates
Table 80. Anthera Pharmaceuticals Corporation Information
Table 81. Anthera Pharmaceuticals Description and Business Overview
Table 82. Anthera Pharmaceuticals Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Anthera Pharmaceuticals Celiac Drugs Product
Table 84. Anthera Pharmaceuticals Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Bayer Celiac Drugs Product
Table 89. Bayer Recent Developments/Updates
Table 90. Biogen Corporation Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Biogen Celiac Drugs Product
Table 94. Biogen Recent Developments/Updates
Table 95. BioLineRx Corporation Information
Table 96. BioLineRx Description and Business Overview
Table 97. BioLineRx Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. BioLineRx Celiac Drugs Product
Table 99. BioLineRx Recent Developments/Updates
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Biotest Celiac Drugs Product
Table 104. Biotest Recent Developments/Updates
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Bristol-Myers Squibb Celiac Drugs Product
Table 109. Bristol-Myers Squibb Recent Developments/Updates
Table 110. Celgene Corporation Information
Table 111. Celgene Description and Business Overview
Table 112. Celgene Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Celgene Celiac Drugs Product
Table 114. Celgene Recent Developments/Updates
Table 115. Celimmune Corporation Information
Table 116. Celimmune Description and Business Overview
Table 117. Celimmune Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Celimmune Celiac Drugs Product
Table 119. Celimmune Recent Developments/Updates
Table 120. F Hoffmann-La Roche Corporation Information
Table 121. F Hoffmann-La Roche Description and Business Overview
Table 122. F Hoffmann-La Roche Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. F Hoffmann-La Roche Celiac Drugs Product
Table 124. F Hoffmann-La Roche Recent Developments/Updates
Table 125. ImmunogenX Corporation Information
Table 126. ImmunogenX Description and Business Overview
Table 127. ImmunogenX Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. ImmunogenX Celiac Drugs Product
Table 129. ImmunogenX Recent Developments/Updates
Table 130. Immunomedics Corporation Information
Table 131. Immunomedics Description and Business Overview
Table 132. Immunomedics Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Immunomedics Celiac Drugs Product
Table 134. Immunomedics Recent Developments/Updates
Table 135. ImmusanT Corporation Information
Table 136. ImmusanT Description and Business Overview
Table 137. ImmusanT Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. ImmusanT Celiac Drugs Product
Table 139. ImmusanT Recent Developments/Updates
Table 140. Innovate Biopharmaceuticals Corporation Information
Table 141. Innovate Biopharmaceuticals Description and Business Overview
Table 142. Innovate Biopharmaceuticals Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Innovate Biopharmaceuticals Celiac Drugs Product
Table 144. Innovate Biopharmaceuticals Recent Developments/Updates
Table 145. Johnson & Johnson Corporation Information
Table 146. Johnson & Johnson Description and Business Overview
Table 147. Johnson & Johnson Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Johnson & Johnson Celiac Drugs Product
Table 149. Johnson & Johnson Recent Developments/Updates
Table 150. Kedrion Biopharma Corporation Information
Table 151. Kedrion Biopharma Description and Business Overview
Table 152. Kedrion Biopharma Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Kedrion Biopharma Celiac Drugs Product
Table 154. Kedrion Biopharma Recent Developments/Updates
Table 155. LFB Group Corporation Information
Table 156. LFB Group Description and Business Overview
Table 157. LFB Group Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. LFB Group Celiac Drugs Product
Table 159. LFB Group Recent Developments/Updates
Table 160. Merck Corporation Information
Table 161. Merck Description and Business Overview
Table 162. Merck Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Merck Celiac Drugs Product
Table 164. Merck Recent Developments/Updates
Table 165. Novartis Corporation Information
Table 166. Novartis Description and Business Overview
Table 167. Novartis Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. Novartis Celiac Drugs Product
Table 169. Novartis Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Celiac Drugs Distributors List
Table 173. Celiac Drugs Customers List
Table 174. Celiac Drugs Market Trends
Table 175. Celiac Drugs Market Drivers
Table 176. Celiac Drugs Market Challenges
Table 177. Celiac Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Celiac Drugs
Figure 2. Global Celiac Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Celiac Drugs Market Share by Type in 2023 & 2030
Figure 4. First Line Of Treatment Product Picture
Figure 5. Second Line Of Treatment Product Picture
Figure 6. Global Celiac Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Celiac Drugs Market Share by Application in 2023 & 2030
Figure 8. Men
Figure 9. Women
Figure 10. Children
Figure 11. Global Celiac Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Celiac Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Celiac Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Celiac Drugs Average Price (USD/Unit) & (2019-2030)
Figure 15. Celiac Drugs Report Years Considered
Figure 16. Celiac Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Celiac Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Celiac Drugs Players: Market Share by Revenue in 2023
Figure 19. Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Celiac Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Celiac Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Celiac Drugs Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Celiac Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Celiac Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Celiac Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Celiac Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Celiac Drugs Sales Market Share by Country (2019-2030)
Figure 45. Latin America Celiac Drugs Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Celiac Drugs Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Celiac Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Celiac Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Celiac Drugs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Celiac Drugs by Type (2019-2030)
Figure 56. Global Celiac Drugs Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Celiac Drugs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Celiac Drugs by Application (2019-2030)
Figure 59. Global Celiac Drugs Price (USD/Unit) by Application (2019-2030)
Figure 60. Celiac Drugs Value Chain
Figure 61. Celiac Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
